Connaughton Bernadette

CIK 00016625213 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001662521

Recent Transactions

32 trades

Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-01-05$70.25/sh−2,000→ 40,123 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$71.60/sh−829→ 42,123 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-10$68.48/sh−2,000→ 42,952 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-01$75.70/sh−500→ 44,952 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-01$75.09/sh−1,500→ 45,452 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-02$71.71/sh−100→ 50,852 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-02$73.62/sh−2,977→ 47,875 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-02$74.11/sh−923→ 46,952 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2025-06-06+37,500→ 37,500 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-05-01+5,750→ 5,750 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-05-01+4,165→ 50,952 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2024-05-30+25,000→ 25,000 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-04-25+6,501→ 46,787 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2024-04-25+8,804→ 8,804 total
Disposition to Issuer
Syneos Health, Inc.
Class A Common Stock
2023-09-28$43.00/sh−9,915→ 4,863 total
Disposition to Issuer
Syneos Health, Inc.
Class A Common Stock
2023-09-28−4,863→ 0 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2023-06-01+25,000→ 25,000 total
Award
Syneos Health, Inc.
Class A Common Stock
2023-05-25+4,863→ 14,778 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2023-05-05+11,371→ 11,371 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2023-05-05+8,065→ 40,286 total
Gift
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2022-11-16−5,998→ 32,221 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2022-06-09+25,000→ 25,000 total
Award
Syneos Health, Inc.
Class A Common Stock
2022-05-25+2,839→ 9,915 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2022-05-05+6,206→ 38,219 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2021-10-26+24,732→ 24,732 total
Award
Syneos Health, Inc.
Class A Common Stock
2021-05-12+2,364→ 7,076 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2021-05-05+5,230→ 32,013 total
Award
Syneos Health, Inc.
Class A Common Stock
2020-05-27$62.43/sh+2,803→ 4,712 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2020-04-30+8,829→ 26,783 total
Award
Syneos Health, Inc.
Class A Common Stock
2019-11-12$49.48/sh+1,909→ 1,909 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2019-05-02+12,173→ 17,954 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2018-09-07+5,781→ 5,781 total

Companies

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov